UBS’s CAREFUSION CORPORATION CFN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$12.3M Buy
271,684
+33,629
+14% +$1.51M 0.01% 1290
2014
Q2
$10.6M Buy
238,055
+134,388
+130% +$5.56M 0.01% 1324
2014
Q1
$4.17M Sell
103,667
-17,799
-15% -$720K ﹤0.01% 2036
2013
Q4
$4.84M Sell
121,466
-62,610
-34% -$2.43M ﹤0.01% 1905
2013
Q3
$6.79M Buy
184,076
+100,369
+120% +$3.75M 0.01% 1443
2013
Q2
$3.08M Buy
+83,707
New +$2.96M ﹤0.01% 2077

Other funds holding CFN

UBS's CFN Position: Q3 2014 in Review

UBS increased its CAREFUSION CORPORATION (CFN) stake by 14% in Q3 2014, buying an estimated $1.51M and bringing the position to 271,684 shares worth $12.3M. The position accounts for 0.01% of the portfolio, ranked #1290.

UBS first reported a position in CFN in Q2 2013 and has held it in 6 quarters since. 417 funds tracked by Wall St. Rank hold CFN as of Q3 2014.

  • UBS held 271,684 shares of CAREFUSION CORPORATION worth $12.3M as of Q3 2014.
  • UBS bought 33,629 CAREFUSION CORPORATION shares in Q3 2014, an estimated $1.51M.
  • CAREFUSION CORPORATION made up 0.01% of UBS's portfolio in Q3 2014, its #1290 holding.
  • UBS first reported a position in CAREFUSION CORPORATION in Q2 2013 and has held it in 6 quarters since.
  • 417 funds tracked by Wall St. Rank held CAREFUSION CORPORATION as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.